1,567
edits
m (→Interventions) |
m (→Outcomes) |
||
Line 91: | Line 91: | ||
==Outcomes== | ==Outcomes== | ||
''Comparisons are Placebo vs. Hydrocortisone plus Fludrocortisone.'' | |||
===Primary Outcomes=== | |||
; All cause mortality at 90 days | |||
: 49% vs. 43% (RR 0.88; 95% CI 0.78-0.99; P=0.03) | |||
===Secondary Outcomes=== | |||
; All cause mortality at 28 days | |||
: 39% vs. 34% (RR 0.87; 95% CI 0.75–1.01; P=0.06) | |||
; All cause mortality at ICU discharge | |||
: 41% vs. 35% (RR 0.86; 95% CI 0.75–0.99; P=0.04) | |||
= | ; All cause mortality at hospital discharge | ||
: 45% vs. 39% (RR 0.86; 95% CI 0.76–0.98; P=0.02) | |||
; All cause mortality at 180 days | |||
: 53% vs. 47% (RR 0.89; 95% CI 0.79–0.99; P=0.04) | |||
; Decision to withdraw care/active treatment at 90 days | |||
: 9% vs. 10% (RR 1.07; 95% CI 0.77–1.49; P=0.69) | |||
; | ; Vasopressor-free days at 28 days | ||
: | : Mean 15±11 vs. 17±11 (P<0.001) | ||
: Median(IRQ) 19(1–26) vs. 23(5–26) | |||
= | ; Ventilator-free days at 28 days | ||
: Mean 10±11 vs. 11±11 (P=0.07) | |||
: Median(IRQ) 4(0–21) vs. 10(0–22) | |||
; | ; Organ-failure-free days at 28 days | ||
: | : Mean 12±11 vs. 14±11 (P=0.003) | ||
: Median(IRQ) 12(0–24) vs. 19(0–25) | |||
===Subgroup Analysis=== | ===Subgroup Analysis=== |
edits